Alternative investment fund Infinity Capital Investments in the first three months of 2024 registered a RON3.17 billion net asset, the highest in the past ten years.
Antibiotice Iasi, the largest Romanian-owned drug manufacturer, saw revenues reach an overall RON192.5 million level, 13% higher than in the year-earlier period.
Romania’s industrial production decreased by 4.2% in unadjusted data in March 2024 versus March 2023 but increased by 2.8% when adjusted for seasonality and the number of working days, data from the country’s statistics board INS showed on Tuesday (May 14, 2024).
Panoramic Restaurant on the Tampa Mountain in Brasov will reopen next year, after ANA Hotels bought it from Aro Palace in 2022 and said it planned to invest in it.
Biodegradable and compostable packaging manufacturer Promateris (PPL.RO) ended the first quarter of 2024 with net profit of RON10.6 million, compared to loss of nearly RON920,000 in the same period of 2023.
Construction company CML.RO in Beclean, Bistrita-Nasaud County, owned by entrepreneurs Mihaela and Vasile Ros, posted RON185.7 million (EUR37.6 million) revenue in 2023, up by about 16% on the RON159.7 million (EUR32.4 million) of 2022, Finance Ministry data show.
Aluminum producer Alro Slatina (ALR.RO) reported net loss of RON14.8 million for the first quarter of 2024, compared to a negative result of RON52.4 million in the same period of 2023, as per its quarterly financial report published at the Bucharest Stock Exchange on May 14.
AROBS Transilvania Software (AROBS.RO), the largest technology company listed on the Bucharest Stock Exchange, posted RON105 million consolidated revenue in the first quarter of 2024, slightly down by 5%, compared with the year-ago period, normalized EBITDA of RON20.6 million and a normalized net profit of RON11.7 million.
Turbomecanica, a local manufacturer of gas turbine engines and mechanical assemblies for aircraft, reported net profit of RON1.3 million for the first quarter of 2024, compared to loss of RON33,000 in the same period of 2023, as per its financial report published at the Bucharest Stock Exchange on May 14.
Pharmaceutical producer Biofarm Bucuresti (BIO.RO) ended the first three months of 2024 with net profit of RON20.6 million, down almost 35% from the same period of 2023, as per its quarterly financial report sent to the Bucharest Stock Exchange.